Suppr超能文献

Tinidazole milk excretion and pharmacokinetics in lactating women.

作者信息

Evaldson G R, Lindgren S, Nord C E, Rane A T

出版信息

Br J Clin Pharmacol. 1985 Apr;19(4):503-7. doi: 10.1111/j.1365-2125.1985.tb02676.x.

Abstract

Five women undergoing acute Caesarean section were given an i.v. dose of 1600 mg tinidazole preoperatively as prophylaxis against anaerobic infection. Blood and breast milk samples were collected at 8 and 4 h intervals, respectively, for 120 h. Tinidazole concentrations were measured by means of high performance liquid chromatography (h.p.l.c). The concentration of tinidazole in breast milk was highly related to the concentration in serum (r = 0.969). Tinidazole concentrations in serum declined monoexponentially with an average half-life of 11.4 h (range 8.7-13.1). The milk/serum concentration ratio varied between 0.62 and 1.39. Seventy-two hours after the Caesarean section the milk concentration exceeded 0.5 microgram/ml in only one woman. It may be calculated that at this time the maximum daily dose to the infant would be 0.1 mg/kg body weight (assuming 3.5 kg body weight and 400 ml milk consumed). We conclude that until tinidazole has been proven harmless to the neonate breast feeding following i.v. administration of 1600 mg should not be initiated earlier than 72 h after the dose.

摘要

相似文献

1
Tinidazole milk excretion and pharmacokinetics in lactating women.
Br J Clin Pharmacol. 1985 Apr;19(4):503-7. doi: 10.1111/j.1365-2125.1985.tb02676.x.
2
Serum and tissue tinidazole concentrations after intravenous infusion.
Chemotherapy. 1983;29(1):13-7. doi: 10.1159/000238167.
3
Comparative pharmacokinetics of metronidazole and tinidazole and their tissue penetration.
Scand J Gastroenterol. 1985 Oct;20(8):945-50. doi: 10.3109/00365528509088853.
4
Pharmacokinetics and metabolism of 14C-tinidazole in humans.
J Antimicrob Chemother. 1986 Jun;17(6):801-9. doi: 10.1093/jac/17.6.801.
5
Tinidazole pharmacokinetics in severe renal failure.
Clin Pharmacokinet. 1984 Jan-Feb;9(1):88-94. doi: 10.2165/00003088-198409010-00005.
6
Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route.
Antimicrob Agents Chemother. 1983 May;23(5):721-5. doi: 10.1128/AAC.23.5.721.
8
Prophylactic oral and intravenous tinidazole in hysterectomy.
J Antimicrob Chemother. 1982 Aug;10 Suppl A:81-3. doi: 10.1093/jac/10.suppl_a.81.

引用本文的文献

3
Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.
Clin Pharmacokinet. 2020 Jul;59(7):827-847. doi: 10.1007/s40262-020-00871-5.
4
Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
Clin Pharmacokinet. 1999 May;36(5):353-73. doi: 10.2165/00003088-199936050-00004.
5
Drugs in human milk. Clinical pharmacokinetic considerations.
Clin Pharmacokinet. 1988 Apr;14(4):217-40. doi: 10.2165/00003088-198814040-00003.
7
Metronidazole excretion in human milk and its effect on the suckling neonate.
Br J Clin Pharmacol. 1988 Jul;26(1):45-51. doi: 10.1111/j.1365-2125.1988.tb03362.x.

本文引用的文献

1
Metronidazole in breast milk.
Obstet Gynecol. 1981 Jan;57(1):48-50.
3
Antimicrobial prophylaxis to prevent mixed bacterial infection.
J Antimicrob Chemother. 1981 Dec;8 Suppl D:115-29. doi: 10.1093/jac/8.suppl_d.115.
4
The pharmacokinetics of intravenous tinidazole in man.
J Antimicrob Chemother. 1981 Oct;8(4):343-4. doi: 10.1093/jac/8.4.343.
5
Post-cesarean section endometritis: causative organisms and risk factors.
Am J Obstet Gynecol. 1980 May 1;137(1):144-5. doi: 10.1016/0002-9378(80)90402-0.
7
Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route.
Antimicrob Agents Chemother. 1983 May;23(5):721-5. doi: 10.1128/AAC.23.5.721.
8
Risk factors in cesarean section infection.
Obstet Gynecol. 1983 Aug;62(2):145-50.
9
Blood and milk concentrations of metronidazole in mothers and infants.
J Perinat Med. 1983;11(2):114-20. doi: 10.1515/jpme.1983.11.2.114.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验